RE:Wer legt den Shorties das Handwerk!Big Pharma: The end of restraint! Stem cell therapies: Diabetes, heart disease, Parkinson's disease - stem cells are supposed to cure everything. Pfizer takes the lead in the potentially most lucrative business with stem cell therapies. The Swiss pharmaceutical company Roche paid millions of US dollars to gain access to their innovative stem cell technologies. Scramble for the top spots ! The list of companies could be extended at will: Novartis, GlaxoSmithKline and AstraZeneca (number 2, 5 and 7 on the list of the largest pharmaceutical companies) have similar activities. As with Roche, the initial focus is on testing pharmacological substances in the laboratory, but one does not have to be a prophet to interpret this as an entry into the therapy business. The scramble for the meat-pot has begun. Source: wissensschau.de